Navigation Links
Genomic Health Announces Multiple Colon Cancer Studies at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Date:1/21/2011

ry is an important advance in efforts by Genomic Health and its collaborators to develop a genomic test that could help physicians better target the use of oxaliplatin in colon cancer patients and highlights the company's commitment to conducting ongoing clinical research in this area.

About Oncotype DX® Colon Cancer Test

The Oncotype DX Colon Cancer test is the first multigene expression test commercially available that has been clinically validated to predict risk of recurrence in patients with stage II colon cancer.  For its colon cancer program, Genomic Health and its collaborators used the same rigorous clinical development strategy and standardized quantitative technology designed for the company's Oncotype DX Breast Cancer test.  National Surgical Adjuvant Breast and Bowel Project (NSABP) conducted three development studies and Cleveland Clinic conducted one development study, all of which were funded by Genomic Health, analyzing 761 genes from 1,851 patients with stage II colon cancer.  The final set of seven recurrence and five reference genes were then independently evaluated in 1,436 stage II colon cancer patients in the QUASAR validation study.  For more information about Oncotype DX for colon cancer, please visit www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is a molecular diagnostics company focused on the global development and commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions.  Its lead product, the Oncotype DX® Breast Cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage ER+ breast cancer.  In addition to this widely adopted test, Genomic Health provides
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Everist Genomics Announces External Validation of OncoDefender™-CRC Test for Predicting Recurrence Risk for Stage I and II Colorectal Cancer Patients
2. BioInformatics, LLC New Market Report - Genomics Technologies
3. Transgenomic Reports Third Quarter Financial Results
4. Transgenomic Awarded $1,070,453 From U.S. Government Under the Patient Protection and Affordable Care Act
5. Transgenomic to Hold Third Quarter Financial Results Conference Call on November 15, 2010
6. Transgenomic Develops New Assays to Detect EGFR Mutations Using COLD-PCR
7. Sirius Genomics Announces Issuance of U.S. Patent
8. AutoGenomics Receives FDA Clearance for its INFINITI® CYP2C19 Assay
9. Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010
10. Dr. Eric Johnson Joins Transgenomic as Medical Director for Laboratory Services
11. WaferGen Names Gary P. Schroth, Ph.D., as New SVP, Genomics Research and Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... new study by researchers from the University of ... nanosystems function, unlocking the potential to create new ... which has been published in the prestigious academic ... novel laser technique to examine in rich detail ... small cluster containing an acetylene molecule and a ...
(Date:7/25/2014)... Diego, CA (PRWEB) July 25, 2014 WABC ... For Your Pet with Lorry Young will be hosting ... to talk about stem cell therapy in pets. Dr. ... the benefits of stem cell therapy for pets suffering from ... moving the Regenerative Veterinary Medicine industry forward. , Young has ...
(Date:7/25/2014)... , July 25, 2014  Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, today announced financial results for the period ... Financial Summary: , Reported cash and cash equivalents ... $137,000 at December 31, 2013.  , Reported a ...
(Date:7/25/2014)... 25, 2014 Sinovac Biotech Ltd. (Nasdaq: ... China , today announced that it will release ... 30, 2014, after market close on Thursday, August 14, 2014 ... the market opening on Friday, August 15, 2014, at 8:00 ... Standard Time) to review the Company,s financial results and provide ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 2Robert J. Harman, DVM, Founder and CEO of Vet-Stem, Inc. to Join New York Radio Host Lorry Young in Upcoming Episode of A “Paws” For Your Pet 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2
... company that provides a smart federated data integration architecture. ( ... Manager Eric Westra that the new name for the company ... ) Imagis was the first of some dozen or so ... Columbia, and in some ways it is the odd-one-out. Vancouver ...
... Wis. - A proposed state ban on all ... Assembly Committee on Children and Families and is headed for ... on a fast track with identical bills - SB 243 ... The legislation has drawn vigorous opposition from both the scientific ...
... Thursday that Joe Hogan, head of GE Healthcare Technologies in ... in London next year as part of the parent ... ,Hogan will succeed Bill Castell as head of GE Healthcare ... of the Waukesha-based GE Healthcare Technologies division since 2000, when ...
Cached Biology Technology:Fleet management vendors capitalize on wireless 2Fleet management vendors capitalize on wireless 3Fleet management vendors capitalize on wireless 4Cloning ban too broad, stem-cell researchers argue 2Cloning ban too broad, stem-cell researchers argue 3Cloning ban too broad, stem-cell researchers argue 4
(Date:7/24/2014)... has different effects on different species of fish, ... of Bristol and Exeter which tested fish anti-predator ... a flying seagull predator model when exposed to ... European minnows. , Lead author Dr Irene ... "Noise levels in many aquatic environments have increased ...
(Date:7/24/2014)... smog-free Los Angeles, where electric cars ply silent freeways, ... heat from beneath the earth, from howling winds and ... study finds that it is technically and economically feasible ... by clean, renewable energy. Published in Energy , ... and reliable energy supply in California that could create ...
(Date:7/24/2014)... sticky research out of York University shows a surprisingly ... toxic grass fungus: moose saliva (yes moose saliva). ... "Ungulate saliva inhibits a grassendophyte mutualism" shows that moose ... (which hosts a fungus called epichlo festucae that produces ... less toxicity. , "Plants have evolved defense mechanisms to ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4Moose drool inhibits growth of toxic fungus: York U research 2
... a cold or flu knows, a high temperature is ... immune reaction when fighting off pathogens. Laboratory studies, in ... in detail, have shown that these responses display significant ... the maximum possible level of intensity? New immunological theories ...
... about positive and negative emotions they often use spatial metaphors. A ... person is down in the dumps. Some researchers believe these metaphors ... do we use spatial words to talk about emotional states, we ... and emotion To test this link between vertical space ...
... two license agreements with SuperPower, a wholly-owned subsidiary ... intellectual property on second generation (2G) high temperature ... Sponsored Research Agreement (SRA) previously executed between the ... by Venkat Selvamanickam, M.D. Anderson chair professor of ...
Cached Biology News:Only some like it hot 2To remember the good times, reach for the sky 2SuperPower and UH sign high temperature superconducting wire license agreements 2
...
Recombinant Rat Leptin, CF...
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... culture systems provide an integrated set-up ... and imaging. Each system uses medical-grade ... coverslips in cell culture plates. The ... ready to use. Individual chambered coverslips ...
Biology Products: